Abstract
Objectives
Screening for lung cancer should be limited to a high-risk-population, and abnormalities in low-dose computed tomography (CT) screening images may be relevant for predicting the risk of lung cancer. Our aims were to compare the occurrence of visually detected emphysema and interstitial abnormalities in subjects with and without lung cancer in a screening population of smokers.
Methods
Low-dose chest CT examinations (baseline and latest possible) of 1990 participants from The Danish Lung Cancer Screening Trial were independently evaluated by two observers who scored emphysema and interstitial abnormalities. Emphysema (lung density) was also measured quantitatively.
Results
Emphysema was seen more frequently and its extent was greater among participants with lung cancer on baseline (odds ratio (OR), 1.8, p = 0.017 and p = 0.002) and late examinations (OR 2.6, p < 0.001 and p < 0.001). No significant difference was found using quantitative measurements. Interstitial abnormalities were more common findings among participants with lung cancer (OR 5.1, p < 0.001 and OR 4.5, p < 0.001).There was no association between presence of emphysema and presence of interstitial abnormalities (OR 0.75, p = 0.499).
Conclusions
Even early signs of emphysema and interstitial abnormalities are associated with lung cancer. Quantitative measurements of emphysema—regardless of type—do not show the same association.
Key Points
• Visually detected emphysema on CT is more frequent in individuals who develop lung cancer.
• Emphysema grading is higher in those who develop lung cancer.
• Interstitial abnormalities, including discrete changes, are associated with lung cancer.
• Quantitative lung density measurements are not useful in lung cancer risk prediction.
• Early CT signs of emphysema and interstitial abnormalities can predict future risk.
Similar content being viewed by others
Abbreviations
- BMI:
-
Body mass index
- COPD:
-
Chronic obstructive pulmonary disease
- CT:
-
Computed tomography
- DLCST:
-
Danish Lung Cancer Screening Trial
- FEV1 :
-
Forced expiratory volume in one second
- HU:
-
Hounsfield units
- ILD:
-
Interstitial lung disease
- IPF:
-
Idiopathic pulmonary fibrosis
- LAA%-910:
-
Low attenuation area percentage under −910 HU
- LAA%-950:
-
Low attenuation area percentage under −950 HU
- PD15:
-
15th percentile density
- pTLC:
-
Predicted total lung capacity
References
Aberle DR, Adams AM, Berg CD et al (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 5:395–409
Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 5:277–300
Bach PB, Mirkin JN, Oliver TK et al (2012) Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 22:2418–29
Field JK, van Klaveren R, Pedersen JH et al (2013) European randomized lung cancer screening trials: Post NLST. J Surg Oncol 5:280–6
Humphrey LL, Deffebach M, Pappas M et al (2013) Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 6:411–20
Field JK, Oudkerk M, Pedersen JH, Duffy SW (2013) Prospects for population screening and diagnosis of lung cancer. Lancet 9893:732–41
McWilliams A, Tammemagi MC, Mayo JR et al (2013) Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med 10:910–9
Tammemagi CM, Pinsky PF, Caporaso NE et al (2011) Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst 13:1058–68
Spitz MR, Etzel CJ, Dong Q et al (2008) An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila) 4:250–4
Bach PB, Kattan MW, Thornquist MD et al (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 6:470–8
Tammemagi MC, Katki HA, Hocking WG et al (2013) Selection criteria for lung-cancer screening. N Engl J Med 8:728–36
Kovalchik SA, Tammemagi M, Berg CD et al (2013) Targeting of low-dose CT screening according to the risk of lung-cancer death. N Engl J Med 3:245–54
Mizuno S, Takiguchi Y, Fujikawa A et al (2009) Chronic obstructive pulmonary disease and interstitial lung disease in patients with lung cancer. Respirology 3:377–83
Gierada DS, Guniganti P, Newman BJ et al (2011) Quantitative CT assessment of emphysema and airways in relation to lung cancer risk. Radiology 3:950–9
Le Jeune I, Gribbin J, West J et al (2007) The incidence of cancer in patients with idiopathic pulmonary fibrosis and sarcoidosis in the UK. Respir Med 12:2534–40
Hubbard R, Venn A, Lewis S, Britton J (2000) Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 1:5–8
Harris JM, Johnston ID, Rudd R, Taylor AJ, Cullinan P (2010) Cryptogenic fibrosing alveolitis and lung cancer: the BTS study. Thorax 1:70–6
Wells C, Mannino DM (1996) Pulmonary fibrosis and lung cancer in the United States: analysis of the multiple cause of death mortality data, 1979 through 1991. South Med J 5:505–10
Jin GY, Lynch D, Chawla A et al (2013) Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2:563–71
Pedersen JH, Ashraf H, Dirksen A et al (2009) The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol 5:608–14
Wille MMW, Thomsen LH, Dirksen A, et al. (2014) Emphysema progression is visually detectable in low-dose CT scans in continuous but not in former smokers. European Radiology
Ashraf H, Lo P, Shaker SB et al (2011) Short-term effect of changes in smoking behaviour on emphysema quantification by CT. Thorax 1:55–60
Dirksen A (2008) Monitoring the progress of emphysema by repeat computed tomography scans with focus on noise reduction. Proc Am Thorac Soc 9:925–8
de Torres JP, Bastarrika G, Wisnivesky JP et al (2007) Assessing the relationship between lung cancer risk and emphysema detected on low-dose CT of the chest. Chest 6:1932–8
Wilson DO, Weissfeld JL, Balkan A et al (2008) Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 7:738–44
Sverzellati N, Guerci L, Randi G et al (2011) Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2:392–400
Kwak N, Park CM, Lee J et al (2014) Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med 3:524–30
Camiciottoli G, Orlandi I, Bartolucci M et al (2007) Lung CT densitometry in systemic sclerosis: correlation with lung function, exercise testing, and quality of life. Chest 3:672–81
Xu Y, van Beek EJ, Hwanjo Y et al (2006) Computer-aided classification of interstitial lung diseases via MDCT: 3D adaptive multiple feature method (3D AMFM). Acad Radiol 8:969–78
Hartley PG, Galvin JR, Hunninghake GW et al (1985) (1994) High-resolution CT-derived measures of lung density are valid indexes of interstitial lung disease. J Appl Physiol 1:271–7
Shaker SB, Stavngaard T, Laursen LC, Stoel BC, Dirksen A (2011) Rapid fall in lung density following smoking cessation in COPD. COPD 1:2–7
Shaker SB, Dirksen A, Lo P et al (2012) Factors influencing the decline in lung density in a Danish lung cancer screening cohort. Eur Respir J 5:1142–8
Acknowledgements
We thank AstraZeneca, Sweden, for financial support. The scientific guarantor of this publication is Asger Dirksen. The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Written informed consent was obtained from all subjects (patients) in this study. Some study subjects or cohorts have been previously reported in DLCST studies regarding nodule characteristics, lung function and lung density. Therefore an extensive overlap between study populations in these publications exists. We have previously published a study on the interobserver agreement and emphysema progression in visual assessments of DLCST scans [21]. The association of visual findings with lung cancer has, however, not previously been explored, and the data from the present study have not been published before. All relevant references are disclosed. Methodology: prospective, diagnostic or prognostic study, performed at one institution.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(DOCX 20 kb)
Rights and permissions
About this article
Cite this article
Wille, M.M.W., Thomsen, L.H., Petersen, J. et al. Visual assessment of early emphysema and interstitial abnormalities on CT is useful in lung cancer risk analysis. Eur Radiol 26, 487–494 (2016). https://doi.org/10.1007/s00330-015-3826-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-3826-9